Alvotech
ALVONasdaq LuxembourgHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$1.780 B
$4.56 -2.35%
Close of 6 Nov 2026
As of 6 Nov 2026, Alvotech (ALVO) has a market capitalization of $1.78B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
—
Not reported
Shares outstanding
312,021,375
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Alvotech lists more than one class of stock. Company figures above cover all classes combined.
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 163 →- #37MesoblastMESO$1.83B
- #38Maze TherapeuticsMAZE$1.80B
- #39AlvotechALVO$1.78B
- #40NovavaxNVAX$1.61B
- #41Lycia TherapeuticsLYCA$1.50B
What if Alvotech were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Alvotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.